_content="""# ORGAN LAYER INDUSTRIALIZATION MODEL

---

## SECTION I — PURPOSE

This document is the constitutional authority governing the industrialized execution of the Organ Layer (Layer 4). No Organ industrialization may commence before the Tissue Layer (Layer 3) is 100% ratified. All Organs must comply with the invariants of their constituent Tissues, Cells, and Organelles, and no Organ may redefine the semantics of these lower layers.

---

## SECTION II — ORGAN DEFINITION

An Organ is a business capability domain composed of coordinated, ratified Tissues.

- An Organ **MUST** be composed only of ratified Tissues.
- An Organ **MAY** express business semantics, as this is the first layer where such expression is constitutionally permitted.
- An Organ **MUST NOT** implement UI primitives.
- An Organ **MUST NOT** define deployment topology.
- An Organ **MUST NOT** bypass the Tissue abstraction to interact directly with Cells or Organelles.
- An Organ **MUST** represent exactly one business capability domain.

---

## SECTION III — INDUSTRIALIZATION GATING RULE

Organ bulk generation is permitted only when the following conditions are met:

- The Tissue Layer is 100% ratified.
- There are no frozen entries in the Tissue Layer.
- The global drift scan is clean.
- Founder authorization has been granted.

Partial unlocking of the Organ Layer is not permitted.

---

## SECTION IV — ORGAN TASK HIERARCHY MODEL

The task hierarchy for an Organ is a strict three-level model:

1.  **Level 1:** Organ Master Issue
2.  **Level 2:** 7 Phase Issues (0–6)
3.  **Level 3:** Atomic Task Units

A minimum of 21 atomic tasks (3 per phase) is required for each Organ. No fourth level is permitted.

---

## SECTION V — ORGAN NUMBERING MODEL

The standardized identifier format for an Organ is:
`ORGX-<DOMAINCODE>-<ORGANNAME>-v<Version>`

- **Master Issue Format:** `[OrganID] Master Issue`
- **Phase Issue Format:** `[OrganID-P#] Phase Name`
- **Atomic Task Format:** `[OrganID-P#-T##] Task Name`
- **Version Inheritance Rule:** An Organ's version must inherit from the versions of its constituent Tissues.

---

## SECTION VI — TISSUE-TO-ORGAN DEPENDENCY MODEL

- All Tissues composing an Organ must be at least **Phase 4 (Verified)** before the Organ's Phase 3 (Implementation) can begin.
- No Organ may depend on an unverified Tissue.
- Dependency declaration is mandatory in the Organ Master Issue.
- No upward dependencies are permitted.

---

## SECTION VII — PHASE SYNCHRONIZATION FLOOR

A cross-layer phase synchronization floor is enforced to maintain stability:

- **Synchronization Floor:** Organ Phase `N` may only begin when all composing Tissues are at or beyond Phase `N+1`.
- **Dependency Verification:** This dependency must be verified before phase transition.
- **Lock Rule:** An Organ is locked if any of its dependent Tissues are frozen or blocked.

---

## SECTION VIII — DOMAIN BOUNDARY ENFORCEMENT

- An Organ must represent exactly one business capability domain.
- No cross-domain merging is permitted without a formal constitutional amendment.
- Domain overlap detection rules must be applied during the design phase.
- Capability duplication detection rules must be applied during the design phase.
- Structural boundary enforcement mechanisms must be implemented to prevent domain leakage.

---

## SECTION IX — PARALLELIZATION RULES

- **Allowed:** Multiple Organs may be in Phase 0 or Phase 1 simultaneously.
- **Not Allowed:** An Organ cannot enter Phase 3 if its Tissue dependencies are not met. Parallel implementation of Organs sharing the same Tissues is not allowed unless explicitly declared and approved. Cross-domain parallelization that risks boundary overlap is forbidden.

---

## SECTION X — DRIFT PREVENTION

The following are specific freeze triggers for the Organ Layer:

- **Domain Boundary Violation:** An Organ performing functions outside its declared business capability domain.
- **Cross-Domain Merging:** An attempt to merge two domains without a constitutional amendment.
- **Business Semantics Leaking:** Business logic leaking into lower layers (Tissues, Cells, or Organelles).
- **Downward Mutation Attempt:** An Organ attempting to alter the behavior of a constituent Tissue.
- **Upward Override Attempt:** An Organ attempting to override the constraints of the System Layer.
- **Deployment Logic Embedding:** An Organ containing deployment-specific logic.

---

## SECTION XI — WAVE EXPANSION MODEL

The Organ Layer will also follow a wave-based industrialization model:

- Wave 1 Organs
- Wave 2 Organs
- Wave 3 Organs

No wave activation is permitted without Founder authorization.

---

## SECTION XII — GLOBAL TRACKER INTEGRATION

Additional tracking requirements for the Organ Layer include:

- Parent Tissues declared
- Business capability domain declared
- Downstream System candidates declared
- Synchronization phase recorded
- Structural risk score calculated

---

## SECTION XIII — RATIFICATION STATEMENT

| | |
|---|---|
| **Status** | RATIFIED |
| **Authority** | Founder |
| **Date** | 2026-02-19 |

This document is constitutionally binding.
"""
